GB9801363D0 - Novel dosage form - Google Patents

Novel dosage form

Info

Publication number: GB9801363D0
Authority: GB; United Kingdom
Prior art keywords: dosage form; novel dosage; novel; dosage
Prior art date: 1998-01-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9801363.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyowa Kirin Services Ltd

Original Assignee

Danbiosyst UK Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-22

Filing date

1998-01-22

Publication date

1998-03-18

1998-01-22 Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd

1998-01-22 Priority to GBGB9801363.4A priority Critical patent/GB9801363D0/en

1998-03-18 Publication of GB9801363D0 publication Critical patent/GB9801363D0/en

1999-01-20 Priority to AU21760/99A priority patent/AU2176099A/en

1999-01-20 Priority to EP99901758A priority patent/EP1059918A1/en

1999-01-20 Priority to PCT/GB1999/000193 priority patent/WO1999037290A1/en

1999-01-20 Priority to JP2000528272A priority patent/JP2002501016A/en

1999-01-20 Priority to CA002318257A priority patent/CA2318257A1/en

1999-01-21 Priority to ZA9900454A priority patent/ZA99454B/en

1999-01-22 Priority to ARP990100264A priority patent/AR014467A1/en

2000-07-14 Priority to NO20003640A priority patent/NO20003640L/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GBGB9801363.4A 1998-01-22 1998-01-22 Novel dosage form Ceased GB9801363D0 (en)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
GBGB9801363.4A GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form
AU21760/99A AU2176099A (en)	1998-01-22	1999-01-20	Novel dosage form
EP99901758A EP1059918A1 (en)	1998-01-22	1999-01-20	Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en)	1998-01-22	1999-01-20	Novel dosage form
JP2000528272A JP2002501016A (en)	1998-01-22	1999-01-20	New dosage form
CA002318257A CA2318257A1 (en)	1998-01-22	1999-01-20	Novel dosage form
ZA9900454A ZA99454B (en)	1998-01-22	1999-01-21	Novel dosage form.
ARP990100264A AR014467A1 (en)	1998-01-22	1999-01-22	ORMALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT OF A SIZE HIGHER THAN 7 MM THAT INCLUDES A DRUG AND EXTERNAL COATING, A METHOD TO PARASEPAR AN ORALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT FROM A DIFFERENT CO-ADMINISTRATED FOOD AND USE COVER
NO20003640A NO20003640L (en)	1998-01-22	2000-07-14	New dosage form

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9801363.4A GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form

Publications (1)

Publication Number	Publication Date
GB9801363D0 true GB9801363D0 (en)	1998-03-18

Family

ID=10825713

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9801363.4A Ceased GB9801363D0 (en)	1998-01-22	1998-01-22	Novel dosage form

Country Status (9)

Country	Link
EP (1)	EP1059918A1 (en)
JP (1)	JP2002501016A (en)
AR (1)	AR014467A1 (en)
AU (1)	AU2176099A (en)
CA (1)	CA2318257A1 (en)
GB (1)	GB9801363D0 (en)
NO (1)	NO20003640L (en)
WO (1)	WO1999037290A1 (en)
ZA (1)	ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9910773D0 (en) *	1999-05-11	1999-07-07	West Pharm Serv Drug Res Ltd	Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) *	2001-01-30	2001-03-14	Smithkline Beecham Plc	Pharmaceutical formulation
WO2006020009A1 (en) *	2004-07-23	2006-02-23	The Procter & Gamble Company	Solid oral dosage form of a bisphosphonate containing a chelating agent
CA2789097C (en)	2005-04-28	2017-02-21	Proteus Digital Health, Inc.	Pharma-informatics system
US8912908B2 (en)	2005-04-28	2014-12-16	Proteus Digital Health, Inc.	Communication system with remote activation
US9198608B2 (en)	2005-04-28	2015-12-01	Proteus Digital Health, Inc.	Communication system incorporated in a container
US8802183B2 (en)	2005-04-28	2014-08-12	Proteus Digital Health, Inc.	Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en)	2006-04-28	2014-09-16	Proteus Digital Health, Inc.	Communication system incorporated in an ingestible product
JP2009544338A (en)	2006-05-02	2009-12-17	プロテウスバイオメディカルインコーポレイテッド	Treatment regimen customized to the patient
SG175681A1 (en)	2006-10-25	2011-11-28	Proteus Biomedical Inc	Controlled activation ingestible identifier
WO2008063626A2 (en)	2006-11-20	2008-05-29	Proteus Biomedical, Inc.	Active signal processing personal health signal receivers
WO2008095183A2 (en)	2007-02-01	2008-08-07	Proteus Biomedical, Inc.	Ingestible event marker systems
WO2008101107A1 (en)	2007-02-14	2008-08-21	Proteus Biomedical, Inc.	In-body power source having high surface area electrode
EP2124725A1 (en)	2007-03-09	2009-12-02	Proteus Biomedical, Inc.	In-body device having a multi-directional transmitter
EP2063771A1 (en)	2007-03-09	2009-06-03	Proteus Biomedical, Inc.	In-body device having a deployable antenna
US8115618B2 (en)	2007-05-24	2012-02-14	Proteus Biomedical, Inc.	RFID antenna for in-body device
EP2192946B1 (en)	2007-09-25	2022-09-14	Otsuka Pharmaceutical Co., Ltd.	In-body device with virtual dipole signal amplification
WO2009070773A1 (en)	2007-11-27	2009-06-04	Proteus Biomedical, Inc.	Transbody communication systems employing communication channels
US8258962B2 (en)	2008-03-05	2012-09-04	Proteus Biomedical, Inc.	Multi-mode communication ingestible event markers and systems, and methods of using the same
MY154234A (en)	2008-07-08	2015-05-15	Proteus Digital Health Inc	Ingestible event marker data framework
WO2010019778A2 (en)	2008-08-13	2010-02-18	Proteus Biomedical, Inc.	Ingestible circuitry
EP2385781A4 (en)	2009-01-06	2014-11-05	Proteus Digital Health Inc	Ingestion-related biofeedback and personalized medical therapy method and system
US8540664B2 (en)	2009-03-25	2013-09-24	Proteus Digital Health, Inc.	Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201810784SA (en)	2009-04-28	2018-12-28	Proteus Digital Health Inc	Highly Reliable Ingestible Event Markers And Methods For Using The Same
WO2010132331A2 (en)	2009-05-12	2010-11-18	Proteus Biomedical, Inc.	Ingestible event markers comprising an ingestible component
TWI517050B (en)	2009-11-04	2016-01-11	普羅托斯數位健康公司	System for supply chain management
SG184494A1 (en)	2010-04-07	2012-11-29	Proteus Biomedical Inc	Miniature ingestible device
TWI557672B (en)	2010-05-19	2016-11-11	波提亞斯數位康健公司	Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
EP2642983A4 (en)	2010-11-22	2014-03-12	Proteus Digital Health Inc	Ingestible device with pharmaceutical product
WO2015112603A1 (en)	2014-01-21	2015-07-30	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
US9756874B2 (en)	2011-07-11	2017-09-12	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
AU2012284125A1 (en)	2011-07-21	2014-02-06	Proteus Digital Health, Inc.	Mobile communication device, system, and method
US9235683B2 (en)	2011-11-09	2016-01-12	Proteus Digital Health, Inc.	Apparatus, system, and method for managing adherence to a regimen
CN104487347B (en)	2012-07-23	2017-09-01	普罗秋斯数字健康公司	Method and system for manufacturing the tablet for including electronic device
DK2910013T3 (en)	2012-10-18	2018-08-06	Proteus Digital Health Inc	Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
WO2014120669A1 (en)	2013-01-29	2014-08-07	Proteus Digital Health, Inc.	Highly-swellable polymeric films and compositions comprising the same
WO2014197402A1 (en)	2013-06-04	2014-12-11	Proteus Digital Health, Inc.	System, apparatus and methods for data collection and assessing outcomes
JP5941240B2 (en)	2013-03-15	2016-06-29	プロテウスデジタルヘルス，インコーポレイテッド	Metal detector device, system and method
US9796576B2 (en)	2013-08-30	2017-10-24	Proteus Digital Health, Inc.	Container with electronically controlled interlock
US10084880B2 (en)	2013-11-04	2018-09-25	Proteus Digital Health, Inc.	Social media networking based on physiologic information
US11051543B2 (en)	2015-07-21	2021-07-06	Otsuka Pharmaceutical Co. Ltd.	Alginate on adhesive bilayer laminate film
JP6552148B1 (en)	2016-07-22	2019-07-31	プロテウスデジタルヘルス，インコーポレイテッド	Electromagnetic sensing and detection of ingestible event markers
US10820831B2 (en)	2016-10-26	2020-11-03	Proteus Digital Health, Inc.	Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) *	2018-06-21	2022-10-04	Mission Pharmacal Company	Enteric coated tiopronin tablet
CN109453166B (en) *	2018-10-16	2021-03-12	丹诺医药(苏州）有限公司	Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) *	2019-10-30	2019-12-27	长春迪瑞制药有限公司	Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4786508A (en) *	1986-05-30	1988-11-22	Warner-Lambert Company	Coated dosage forms
FR2618331B1 (en) *	1987-07-23	1991-10-04	Synthelabo	PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
NZ228557A (en) *	1988-04-05	1990-11-27	Kyowa Hakko Kogyo Kk	Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

1998
- 1998-01-22 GB GBGB9801363.4A patent/GB9801363D0/en not_active Ceased
1999
- 1999-01-20 JP JP2000528272A patent/JP2002501016A/en active Pending
- 1999-01-20 CA CA002318257A patent/CA2318257A1/en not_active Abandoned
- 1999-01-20 WO PCT/GB1999/000193 patent/WO1999037290A1/en not_active Ceased
- 1999-01-20 EP EP99901758A patent/EP1059918A1/en not_active Withdrawn
- 1999-01-20 AU AU21760/99A patent/AU2176099A/en not_active Abandoned
- 1999-01-21 ZA ZA9900454A patent/ZA99454B/en unknown
- 1999-01-22 AR ARP990100264A patent/AR014467A1/en unknown
2000
- 2000-07-14 NO NO20003640A patent/NO20003640L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA99454B (en)	2000-10-23
CA2318257A1 (en)	1999-07-29
WO1999037290A1 (en)	1999-07-29
AR014467A1 (en)	2001-02-28
NO20003640L (en)	2000-09-12
JP2002501016A (en)	2002-01-15
EP1059918A1 (en)	2000-12-20
AU2176099A (en)	1999-08-09
NO20003640D0 (en)	2000-07-14

Publication	Publication Date	Title
GB9801363D0 (en)	1998-03-18	Novel dosage form
GB9817118D0 (en)	1998-10-07	Pharmaceutical compounds
PL341642A1 (en)	2001-04-23	Novel macrolydes
GB9817623D0 (en)	1998-10-07	Pharmaceutical compounds
GB9810886D0 (en)	1998-07-22	Pharmaceutical compounds
PL343627A1 (en)	2001-08-27	Medicinal compositions
HU9901830D0 (en)	1999-07-28	Nefazodone dosage form
PT1466615E (en)	2009-09-07	Pharmaceutical composition
PL343769A1 (en)	2001-09-10	Pharmaceutical composition
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
EP1068213A4 (en)	2001-05-02	Novel aminoorganofunctionalsiloxanes
GB9800750D0 (en)	1998-03-11	Pharmaceutical compound
GB9823847D0 (en)	1998-12-23	Pharmaceutical compounds
GB9823845D0 (en)	1998-12-23	Pharmaceutical compounds
GB9808665D0 (en)	1998-06-24	Therapeutic compounds
PL338781A1 (en)	2000-11-20	Dosage form
GB9824897D0 (en)	1999-01-06	Therapeutic compounds
GB9817197D0 (en)	1998-10-07	Pharmaceutical compounds
GB9827865D0 (en)	1999-02-10	Medicament
TW407677U (en)	2000-10-01	Form
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition
GB9718683D0 (en)	1997-11-05	Novel dosage form
GB9808667D0 (en)	1998-06-24	Therapeutic compounds
ZA989425B (en)	1999-07-28	Dosage form
GB9821694D0 (en)	1998-12-02	Amphiphilogel dosage form

Legal Events

Date	Code	Title	Description
1999-04-14	AT	Applications terminated before publication under section 16(1)